Heterologous expression systems for study of cystic fibrosis transmembrane conductance regulator.
Chang
X B
XB
Mayo Clinic, Scottsdale, Scottsdale, Arizona 85259, USA.
Kartner
N
N
Seibert
F S
FS
Aleksandrov
A A
AA
Kloser
A W
AW
Kiser
G L
GL
Riordan
J R
JR
D000818:Animals; D016367:Baculoviridae; D016466:CHO Cells; D019556:COS Cells; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D018118:Chloride Channels / Q000096:biosynthesis / Q000502:physiology; D003001:Cloning, Molecular / Q000379:methods; D006224:Cricetinae; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000096:biosynthesis* / Q000502:physiology*; D005260:Female; D006801:Humans; D015640:Ion Channel Gating; D008564:Membrane Potentials / Q000502:physiology; D008727:Methotrexate / Q000633:toxicity; D009865:Oocytes / Q000502:physiology; D010957:Plasmids; D011994:Recombinant Proteins / Q000096:biosynthesis; D015183:Restriction Mapping; D012441:Saccharomyces cerevisiae; D018411:Spodoptera; D014162:Transfection / Q000379:methods; D014982:Xenopus laevis
C505032:CFTR protein, human; D018118:Chloride Channels; D011994:Recombinant Proteins; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D008727:Methotrexate